IMNM SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0002100119-26-001633
IMNM filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 30, 2026. A Schedule 13G was filed regarding Immunome Inc. (IMNM), indicating a passive investor's beneficial ownership position. The stock moved -0.4% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Immunome Inc. (IMNM), indicating a passive investor's beneficial ownership position. The filing text provided is only the EDGAR directory listing and does not contain the substantive ownership details.
Key details
How IMNM stock reacted
Close before
$18.29
Oct 29, 2026
First close after
-0.44%
$18.21
5 trading days
—
Since filing
+9.57%
$20.04
✦ Ask GOAX AI about this filing — what it means for IMNM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMNM?
Click hereFrequently asked questions
What did IMNM file with the SEC on Oct 30, 2026?
IMNM filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Immunome Inc. (IMNM), indicating a passive investor's beneficial ownership position. The filing text provided is only the EDGAR directory listing and does not contain the substantive ownership details.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did IMNM stock react to this filing?
IMNM closed at $18.29 before the filing and $18.21 on Oct 30, 2026 (-0.44%).
Other IMNM SEC filings
Get alerts when IMNM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days